Valuation Alfresa Holdings Corporation

Stocks

Market Closed - Japan Exchange 10:30:00 11/09/2026 +04			5-day change	1st Jan Change
2,295.00 ^JPY	0.00%		-0.58%	-5.59%

07-01	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI
06-22	Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	343,826	343,217	415,318	383,847	459,384	402,574	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-12.37%	-	-
Enterprise Value (EV)	168,429	186,950	236,499	242,307	301,938	402,574	402,574	402,574
Change	-	11%	26.5%	2.46%	24.61%	33.33%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	17.5x	14.5x	15.2x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.8x	0.77x	0.77x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.7x	-3.23x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.13x	0.12x	0.12x
EV / Revenue	0x	0x	0x	0x	0x	0.13x	0.12x	0.12x
EV / EBITDA	0x	0x	0x	0x	0x	8.15x	7.92x	7.67x
EV / EBIT	0x	0x	0x	0x	0x	11.7x	10.8x	10.6x
EV / FCF	0x	-0x	0x	-0x	0x	19.2x	24.6x	33.5x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	5.22%	4.06%	2.98%
Dividend per Share ²	54	57	70	63	68	71	79	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	3.09%	3.44%	3.7%
EPS ²	153.6	127.4	154.1	147.5	229.6	131.1	158	150.6
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	54.2%	50%	56.5%
Net sales ¹	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064	3,188,539	3,279,596	3,340,075
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	49,400	50,836	52,514
EBIT ¹	29,091	30,148	38,460	38,080	36,164	34,453	37,402	38,069
Net income ¹	32,182	25,786	29,558	27,389	41,746	23,486	27,351	26,886
Net Debt	-175,397	-156,267	-178,819	-141,540	-157,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,295.00	2,295.00	2,295.00
Nbr of stocks (in thousands)	202,370	202,369	186,870	181,789	181,719	175,413	-	-
Announcement Date	16/05/22	15/05/23	14/05/24	15/05/25	15/05/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALFRESA HOLDINGS CORPORATION	17.51x	-	-	3.09%	2.62B
ABBOTT LABORATORIES	28.88x	3.99x	15.42x	2.52%	176B
MEDTRONIC PLC	19.24x	3.52x	12.58x	3.12%	116B
CENCORA, INC.	17.61x	0.2x	12.86x	0.74%	61.36B
HOYA CORPORATION	27.83x	6.83x	17.6x	1.44%	49.42B
BECTON, DICKINSON AND COMPANY	34.27x	3.34x	11.43x	2.21%	48.44B
DEXCOM, INC.	33.28x	5.85x	18.35x	-.--%	31.33B
MEDLINE INC.	42x	1.24x	11.46x	0.22%	28.56B
WEST PHARMACEUTICAL SERVICES, INC.	40.38x	7.07x	25.37x	0.26%	24.37B
TERUMO CORPORATION	16.74x	2.67x	9.46x	1.65%	21.57B
Average	27.77x	3.86x	14.95x	1.53%	56.04B
Weighted average by Cap.	26.91x	3.72x	14.56x	1.94%